Since the first semaglutide drug was approved in 2005, patients and manufacturers have seen many changes: shortages, compounding, and more than a thousand lawsuits from patients who experienced severe side effects under these drugs, including stomach paralysis, bowel obstruction, and vision loss
Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
Oxidative Stress Relief: Strategically formulated with Glutathione to wash away environmental pollutants that cause skin dullness, ensuring a refreshed and radiant complexion immediately after use
The Wegovy pill isnt FDA-approved for diabetes, although clinical trials do show reduction in blood sugar for those with prediabetes over the course of 64 weeks
also supports hair, skin and nails* Cognitive Support: Methylated Folate (Metafolin L-5-MTHF) and vitamin B12 support healthy cognitive function, memory, and energy
